IT1159739B - Composti eterociclici, particolarmente utili come medicamenti, e procedimento per la loro preparazione - Google Patents
Composti eterociclici, particolarmente utili come medicamenti, e procedimento per la loro preparazioneInfo
- Publication number
- IT1159739B IT1159739B IT68450/78A IT6845078A IT1159739B IT 1159739 B IT1159739 B IT 1159739B IT 68450/78 A IT68450/78 A IT 68450/78A IT 6845078 A IT6845078 A IT 6845078A IT 1159739 B IT1159739 B IT 1159739B
- Authority
- IT
- Italy
- Prior art keywords
- medications
- procedure
- preparation
- particularly useful
- heterocyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2574077 | 1977-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7868450A0 IT7868450A0 (it) | 1978-06-20 |
| IT1159739B true IT1159739B (it) | 1987-03-04 |
Family
ID=10232513
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT7868449A IT7868449A0 (it) | 1977-06-20 | 1978-06-20 | Aminoacidi ciclici particolarmente utili per medicamenti e procedimento per la loro preparazione |
| IT68450/78A IT1159739B (it) | 1977-06-20 | 1978-06-20 | Composti eterociclici, particolarmente utili come medicamenti, e procedimento per la loro preparazione |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT7868449A IT7868449A0 (it) | 1977-06-20 | 1978-06-20 | Aminoacidi ciclici particolarmente utili per medicamenti e procedimento per la loro preparazione |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4278676A (it) |
| EP (4) | EP0028017A1 (it) |
| JP (2) | JPS5436275A (it) |
| AT (1) | AT368505B (it) |
| AU (2) | AU3724478A (it) |
| CA (1) | CA1107736A (it) |
| DK (2) | DK270278A (it) |
| ES (2) | ES470912A1 (it) |
| FI (2) | FI64376C (it) |
| IE (1) | IE47200B1 (it) |
| IT (2) | IT7868449A0 (it) |
| NO (3) | NO152049C (it) |
| NZ (1) | NZ187615A (it) |
| ZA (2) | ZA783493B (it) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3145473A1 (de) * | 1980-11-27 | 1982-08-26 | Kefalas A/S, Koebenhavn-Valby | 2-substituierte 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-on-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| DE3145474A1 (de) * | 1980-11-27 | 1982-09-02 | Kefalas A/S, Koebenhavn-Valby | 3-substituierte 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| EP0083378A1 (en) * | 1981-12-22 | 1983-07-13 | Chugai Seiyaku Kabushiki Kaisha | Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same |
| GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
| IT1228426B (it) * | 1987-07-20 | 1991-06-17 | Ausimont Spa | Perossiacidi eterociclici |
| US4859666A (en) * | 1988-07-06 | 1989-08-22 | Bristol-Myers Company | THAZ derivatives for enhancement of cerebral function |
| CN1043051C (zh) * | 1994-07-22 | 1999-04-21 | 国际壳牌研究有限公司 | 制备氢化石蜡的方法 |
| ES2341004T3 (es) | 2003-06-25 | 2010-06-14 | H. Lundbeck A/S | Gaboxadol para tratar la depresion y otros trastornos afectivos. |
| US20050234093A1 (en) * | 2003-06-25 | 2005-10-20 | H. Lundbeck A/S | Treatment of depression and other affective disorders |
| AR045540A1 (es) * | 2003-09-05 | 2005-11-02 | Lundbeck & Co As H | Metodo de elaboracion de 4,5,6,7 tetrahidroisoxazol [5,4-c] piridin-3-ol (thip) |
| ES2515092T3 (es) * | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión |
| US20050137222A1 (en) * | 2003-12-18 | 2005-06-23 | H. Lundbeck A/S | Treatment of insomnia in human patients |
| US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
| JP2007517040A (ja) * | 2003-12-24 | 2007-06-28 | セプレイコー インコーポレイテッド | 睡眠の質を改善するためのメラトニン併用療法 |
| GB0402118D0 (en) * | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| WO2005079851A2 (en) * | 2004-02-18 | 2005-09-01 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
| WO2006083682A2 (en) | 2005-01-28 | 2006-08-10 | H.Lundbeck A/S | Polymorphic forms of a gabaa agonist |
| WO2006118897A1 (en) * | 2005-04-29 | 2006-11-09 | H.Lundbeck A/S | Acid and base salt forms of gaboxadol |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100193652A1 (en) * | 2009-02-02 | 2010-08-05 | William Stajos | Wall Display System And Method Of Providing The Same |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US8784835B2 (en) * | 2012-07-02 | 2014-07-22 | Trent Austin | Method for producing muscimol and/or reducing ibotenic acid from amanita tissue |
| CN104974175A (zh) * | 2014-04-11 | 2015-10-14 | 天津药物研究院 | 一种氨甲基羟异恶唑类似物的制备方法 |
| US20150352085A1 (en) | 2014-06-06 | 2015-12-10 | Ovid Therapeutics Inc. | Methods of increasing tonic inhibition and treating secondary insomnia |
| WO2016150953A1 (en) * | 2015-03-24 | 2016-09-29 | H. Lundbeck A/S | Manufacture of 4,5,6,7-tetrahydroisozaxolo[5,4-c]pyridin-3-ol |
| US9682069B2 (en) | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
| IL256912B2 (en) | 2015-07-17 | 2024-01-01 | Ovid Therapeutics Inc | Methods for treating developmental disorders with gaboxadol |
| US9399034B1 (en) | 2015-08-11 | 2016-07-26 | Ovid Therapeutics Inc | Methods of sedation during critical care treatment |
| WO2018031748A1 (en) | 2016-08-11 | 2018-02-15 | Ovid Therapeutics Inc. | Methods and compositions for treatment of epileptic disorders |
| US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
| US20180338959A1 (en) | 2017-05-24 | 2018-11-29 | Ovid Therapeutics Inc. | Treatment of depressive disorders |
| WO2019028234A1 (en) | 2017-08-04 | 2019-02-07 | Ovid Therapeutics Inc. | USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS |
| US10765666B2 (en) | 2018-09-20 | 2020-09-08 | Ovid Therapeutics Inc | Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering |
| CA3120856A1 (en) | 2018-11-21 | 2020-05-28 | Certego Therapeutics, Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
| US11690829B2 (en) | 2018-12-17 | 2023-07-04 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder |
| WO2021236876A2 (en) | 2020-05-20 | 2021-11-25 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
| CN114292224B (zh) * | 2022-03-07 | 2022-05-20 | 中国农业科学院农产品加工研究所 | 一种大麻二酚-2-（n-乙酰基）哌啶酸酯及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2784190A (en) * | 1952-03-28 | 1957-03-05 | Upjohn Co | Alkyl piperidinepropionates |
| CA762455A (en) * | 1962-03-22 | 1967-07-04 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyrido-pyrimidines |
| US3381016A (en) * | 1966-03-04 | 1968-04-30 | Upjohn Co | Isoxazolo[5, 4-b]pyridine derivatives and a method for their preparation |
| DE2221770A1 (de) * | 1972-05-04 | 1973-11-15 | Bayer Ag | Verfahren zur herstellung von tetrahydropyridinen |
| DK62791A (da) * | 1991-04-09 | 1992-11-09 | Tulip Int As | Fremgangsmaade til saltning af koed samt anlaeg til brug ved udoevelse af fremgangsmaaden |
-
1978
- 1978-06-15 DK DK270278A patent/DK270278A/da unknown
- 1978-06-15 DK DK270378A patent/DK270378A/da unknown
- 1978-06-19 ZA ZA00783493A patent/ZA783493B/xx unknown
- 1978-06-19 NZ NZ187615A patent/NZ187615A/xx unknown
- 1978-06-19 ZA ZA00783492A patent/ZA783492B/xx unknown
- 1978-06-19 ES ES470912A patent/ES470912A1/es not_active Expired
- 1978-06-19 IE IE1234/78A patent/IE47200B1/en unknown
- 1978-06-19 EP EP80106498A patent/EP0028017A1/en not_active Withdrawn
- 1978-06-19 EP EP78100191A patent/EP0000338B1/en not_active Expired
- 1978-06-19 NO NO782127A patent/NO152049C/no unknown
- 1978-06-19 FI FI781954A patent/FI64376C/fi not_active IP Right Cessation
- 1978-06-19 FI FI781955A patent/FI781955A/fi not_active Application Discontinuation
- 1978-06-19 EP EP78100190A patent/EP0000167A1/en not_active Withdrawn
- 1978-06-19 NO NO782128A patent/NO782128L/no unknown
- 1978-06-19 AU AU37244/78A patent/AU3724478A/en active Pending
- 1978-06-19 EP EP80106497A patent/EP0027279A1/en not_active Withdrawn
- 1978-06-19 ES ES470913A patent/ES470913A1/es not_active Expired
- 1978-06-19 US US05/917,118 patent/US4278676A/en not_active Expired - Lifetime
- 1978-06-20 CA CA305,798A patent/CA1107736A/en not_active Expired
- 1978-06-20 IT IT7868449A patent/IT7868449A0/it unknown
- 1978-06-20 IT IT68450/78A patent/IT1159739B/it active
- 1978-06-20 AT AT0448678A patent/AT368505B/de not_active IP Right Cessation
- 1978-06-20 JP JP7479978A patent/JPS5436275A/ja active Pending
- 1978-06-20 JP JP7480078A patent/JPS5436290A/ja active Pending
- 1978-06-20 AU AU37298/78A patent/AU521040B2/en not_active Expired
-
1979
- 1979-09-03 NO NO792839A patent/NO792839L/no unknown
- 1979-12-17 US US06/104,080 patent/US4301287A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ187615A (en) | 1981-12-15 |
| JPS5436275A (en) | 1979-03-16 |
| NO152049C (no) | 1985-07-24 |
| EP0000338A3 (en) | 1979-06-27 |
| ZA783493B (en) | 1979-06-27 |
| ATA448678A (de) | 1982-02-15 |
| US4301287A (en) | 1981-11-17 |
| AU521040B2 (en) | 1982-03-11 |
| DK270378A (da) | 1978-12-21 |
| EP0000167A1 (en) | 1979-01-10 |
| FI781954A (fi) | 1978-12-21 |
| EP0028017A1 (en) | 1981-05-06 |
| EP0000338A2 (en) | 1979-01-24 |
| FI64376B (fi) | 1983-07-29 |
| AT368505B (de) | 1982-10-25 |
| AU3724478A (en) | 1980-01-03 |
| EP0000338B1 (en) | 1981-11-25 |
| ES470913A1 (es) | 1979-02-01 |
| DK270278A (da) | 1978-12-21 |
| IT7868449A0 (it) | 1978-06-20 |
| NO782128L (no) | 1978-12-21 |
| ZA783492B (en) | 1979-06-27 |
| AU3729878A (en) | 1980-01-03 |
| FI781955A (fi) | 1978-12-21 |
| FI64376C (fi) | 1983-11-10 |
| IE47200B1 (en) | 1984-01-11 |
| NO792839L (no) | 1978-12-21 |
| CA1107736A (en) | 1981-08-25 |
| US4278676A (en) | 1981-07-14 |
| EP0027279A1 (en) | 1981-04-22 |
| IT7868450A0 (it) | 1978-06-20 |
| NO152049B (no) | 1985-04-15 |
| ES470912A1 (es) | 1979-02-01 |
| IE781234L (en) | 1978-12-20 |
| JPS5436290A (en) | 1979-03-16 |
| NO782127L (no) | 1978-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1159739B (it) | Composti eterociclici, particolarmente utili come medicamenti, e procedimento per la loro preparazione | |
| IT7820811A0 (it) | Fenossi-benzil-ossicarbonil-derivati sostituiti, procedimento per laloro preparazione e loro impiegocome insetticidi e come acaricidi. | |
| IT7825315A0 (it) | Fenossi-benzil-ossicarbonilderivati sostituiti, procedimento per la loro preparazione e loro impiego come insetticidi e come acaricidi. | |
| IT7826792A0 (it) | Nitroimmidazoli e procedimento per la loro preparazione. | |
| IT1104127B (it) | Feniletanolammine sostituite utili come componenti di farmaci e procedimento per la loro preparazione | |
| IT1113092B (it) | Composti eterociclici,procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali composti | |
| IT7827624A0 (it) | Cefemi composti e procedimenti per la loro preparazione. | |
| IT1156863B (it) | Composti di beta-lattame e procedimento per la loro preparazione | |
| IT1092954B (it) | Fenilcarbammoil-pirazoline,procedimento per la loro preparazione e il loro impiego come insetticidi | |
| IT1092953B (it) | Fenil-carbammoil-2-pirazoline sostituite,procedimento per la loro preparazione e loro impiego come insetticidi | |
| IT7825106A0 (it) | Acetilenprostaglandine eprocedimento per la loro preparazione. | |
| IT1160450B (it) | Composti nitrosureici e procedimento per la loro preparazione | |
| IT1098005B (it) | Composti di organostagno,loro preparazione e loro impiego | |
| IT7827077A0 (it) | Fenileteri eterociclici e processo per la loro preparazione. | |
| IT1106961B (it) | Composti antifungo ed antibatterici e procedimento per la loro preparazione | |
| IT1108792B (it) | Composti fenossi alcanolici sostituiti particolarmente utili come medicamenti e procedimento per la loro preparazione | |
| IT1111459B (it) | Composti pesticidi e procedimento per la loro preparazione | |
| IT1100210B (it) | 2,4-diammino-5-benzil-pirimidine e procedimento per la loro preparazione | |
| IT7822440A0 (it) | N-fenilformamidossime sostituite e processo per la loro preparazione. | |
| IT1098266B (it) | 2-sostituti-3-fenilindoli,procedimento per la loro preparazione e per il loro impiego come immunosoppresori | |
| IT7830778A0 (it) | 3-di-n-propil-acetossi-benzo-diazepin-2-oni e procedimento per la loro preparazione. | |
| IT1059486B (it) | N..sulfonil..n..dialogenofenil..imidazolidin..dioni..particolarmente utili come microbicidi industriali..e procedimento per la loro preparazione | |
| IT7851612A0 (it) | Aril-tiocarbossilati tiocianometili ci e procedimento per la loro produzione e applicazione | |
| IT7823093A0 (it) | Benzil-pirimidine e procedimento per la loro preparazione. | |
| IT7825712A0 (it) | Composti di b-lattami, procedimento per la loro preparazione e loro impiego. |